Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma
To evaluate the prognostic impact of the protein expression of both PBRM1 and BAP1 in metastatic tissue of patients with metastatic clear cell renal cell carcinoma (ccRCC).
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Walter Henriques da Costa, Aline Fusco Fares, Stephania M. Bezerra, Mariana A Morini, Ligia Alencar de Toledo Benigno, Diego Abreu Clavijo, Lucas Fornazieri, Maur ício Murce Rocha, Isabela Werneck da Cunha, Stenio de Cassio Zequi Tags: Original Article Source Type: research
More News: Cancer & Oncology | Carcinoma | Kidney Cancer | Renal Cell Carcinoma | Urology & Nephrology